These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 14529055

  • 21. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 22. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ, Charlesworth BR, Green J, Färkkilä M, Diener HC, Hansen SB, Gawel M, INDEX Study Group.
    Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
    [Abstract] [Full Text] [Related]

  • 23. An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients.
    Pascual J, Muñoz R, Leira R.
    Cephalalgia; 2001 Jul; 21(6):680-4. PubMed ID: 11531900
    [Abstract] [Full Text] [Related]

  • 24. Difference in triptan effect in patients with migraine and early allodynia.
    Lampl C, Huber G, Haas S, Rittberger E, Diener HC.
    Cephalalgia; 2008 Oct; 28(10):1031-8. PubMed ID: 18624801
    [Abstract] [Full Text] [Related]

  • 25. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
    Freitag F, Taylor FR, Hamid MA, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
    [Abstract] [Full Text] [Related]

  • 26. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M, Marbury T, O'Neill C, Siegel S, Du W, Sebree T.
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [Abstract] [Full Text] [Related]

  • 27. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
    Loder E, Freitag FG, Adelman J, Pearlmand S, Abu-Shakra S.
    Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
    [Abstract] [Full Text] [Related]

  • 28. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 29. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P, Landy S, Richardson M, Ames M.
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 31. Clinical applications of new therapeutic deliveries in migraine.
    Dahlöf C.
    Neurology; 2003 Oct 28; 61(8 Suppl 4):S31-4. PubMed ID: 14581656
    [Abstract] [Full Text] [Related]

  • 32. Rizatriptan. Convenience and consistency.
    Evans RW.
    Postgrad Med; 2000 Sep 28; 108(3 Suppl):10-5. PubMed ID: 19667525
    [Abstract] [Full Text] [Related]

  • 33. Sumatriptan and zolmitriptan.
    Nurs Times; 2000 Sep 28; 101(39):31. PubMed ID: 16218117
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
    Pascual J, Bussone G, Hernandez JF, Allen C, Vrijens F, Patel K, Rizatriptan-Sumatriptan Preference Study Group.
    Eur Neurol; 2001 Sep 28; 45(4):275-83. PubMed ID: 11385269
    [Abstract] [Full Text] [Related]

  • 35. [Clinical efficacy of zolmitriptan in migraine].
    Leira R, Noya M.
    Neurologia; 1998 Oct 28; 13 Suppl 2():16-24. PubMed ID: 9859691
    [Abstract] [Full Text] [Related]

  • 36. [Experience with intranasal zolmitriptan in cluster headache].
    Pascual J, Navarro A, Caminero AB, Jurado C.
    Neurologia; 2006 Apr 28; 21(3):131-4. PubMed ID: 16575626
    [Abstract] [Full Text] [Related]

  • 37. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine.
    Gallagher RM, Dennish G, Spierings EL, Chitra R.
    Headache; 2000 Feb 28; 40(2):119-28. PubMed ID: 10759911
    [Abstract] [Full Text] [Related]

  • 38. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlöf CG, Mateos V, Dowson AJ, Raets I, Cunha L, Färkkilä M, Manzoni GC.
    Acta Neurol Scand; 2007 Jan 28; 115(1):34-40. PubMed ID: 17156263
    [Abstract] [Full Text] [Related]

  • 39. Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group.
    Dowson AJ, Ashford EA, Prendergast S, Hassani H, Roberts GW, Flöter T, Szczudlik A.
    Int J Clin Pract Suppl; 1999 Aug 28; 105():25-33. PubMed ID: 10692719
    [Abstract] [Full Text] [Related]

  • 40. Improved migraine management in primary care: results of a patient treatment experience study using zolmitriptan orally disintegrating tablet.
    Shapero G, Dowson A, Lacoste JP, Almqvist P.
    Int J Clin Pract; 2006 Dec 28; 60(12):1530-5. PubMed ID: 17109663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.